Jun 11, 2011
Phico Therapeutics successfully raises £1m to develop products in their antibiotic platform technology, SASPjectTM, which is combats the problem of antibiotic resistance and bacterial toxin release when treating patients infected with E. Coli.
Oct 26, 2010
Wellcome Trust funded biotech Phico Therapeutics has attracted to their Board, Dr Anthony F. Martin, an experienced Non-Exec with solid track record of guiding early stage companies through to market.